BIOMAT Database Logo BIOMAT Database Logo

Chloroquine and proguanil prophylaxis in travellers to Kenya. 1992

L K Basco, and J Le Bras, and G Charmot, and J L Vilde, and F Vachon, and J P Coulaud

UI MeSH Term Description Entries
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000350 Africa, Central The geographical area of Africa comprising CAMEROON; CENTRAL AFRICAN REPUBLIC; CHAD; CONGO; DEMOCRATIC REPUBLIC OF THE CONGO; EQUATORIAL GUINEA; GABON; and SAO TOME AND PRINCIPE. Central Africa
D000354 Africa, Western The geographical area of Africa comprising BENIN; BURKINA FASO; CABO VERDE, COTE D'IVOIRE (formerly Ivory Coast); GAMBIA; GHANA; GUINEA; GUINEA-BISSAU; LIBERIA; MALI; MAURITANIA; NIGER; NIGERIA; SENEGAL; SIERRA LEONE; and TOGO. Africa, West,West Africa,Western Africa
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D014195 Travel MOVEMENT across different GEOGRAPHIC LOCATIONS. Land Travel,Sea Travel,Land Travels,Sea Travels,Travel, Land,Travel, Sea,Travels,Travels, Land,Travels, Sea
D016778 Malaria, Falciparum Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. Plasmodium falciparum Malaria,Malaria, Plasmodium falciparum

Related Publications

L K Basco, and J Le Bras, and G Charmot, and J L Vilde, and F Vachon, and J P Coulaud
Chloroquine and proguanil prophylaxis in travellers to Kenya.
January 1992, Lancet (London, England),
L K Basco, and J Le Bras, and G Charmot, and J L Vilde, and F Vachon, and J P Coulaud
Chloroquine and proguanil prophylaxis in travellers to Kenya.
January 1992, Lancet (London, England),
L K Basco, and J Le Bras, and G Charmot, and J L Vilde, and F Vachon, and J P Coulaud
Chloroquine and proguanil prophylaxis in travellers to Kenya.
January 1992, Lancet (London, England),
L K Basco, and J Le Bras, and G Charmot, and J L Vilde, and F Vachon, and J P Coulaud
Failure of chloroquine and proguanil prophylaxis in travellers to Kenya.
November 1991, Lancet (London, England),
L K Basco, and J Le Bras, and G Charmot, and J L Vilde, and F Vachon, and J P Coulaud
Malarial prophylaxis with chloroquine/proguanil.
January 1987, The Medical journal of Australia,
L K Basco, and J Le Bras, and G Charmot, and J L Vilde, and F Vachon, and J P Coulaud
Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.
December 2000, Lancet (London, England),
L K Basco, and J Le Bras, and G Charmot, and J L Vilde, and F Vachon, and J P Coulaud
[Compliance in malaria prophylaxis with chloroquine and proguanil].
March 1991, Deutsche medizinische Wochenschrift (1946),
L K Basco, and J Le Bras, and G Charmot, and J L Vilde, and F Vachon, and J P Coulaud
Diagnosis of malaria during chloroquine/proguanil prophylaxis.
January 1990, Lancet (London, England),
L K Basco, and J Le Bras, and G Charmot, and J L Vilde, and F Vachon, and J P Coulaud
Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil.
June 1995, The Journal of infectious diseases,
L K Basco, and J Le Bras, and G Charmot, and J L Vilde, and F Vachon, and J P Coulaud
Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine.
March 1988, British medical journal (Clinical research ed.),
Copied contents to your clipboard!